ºÝºÝߣshows by User: KelvinStott / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: KelvinStott / Mon, 12 Mar 2012 20:53:20 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: KelvinStott Understanding Risk & Uncertainty /slideshow/kelvin-stott-risk-and-uncertainty/11981004 kelvinstott-riskanduncertainty-120312205323-phpapp02
Risk and uncertainty are related, but different concepts that many people struggle to understand. This presentation defines and explains the difference between risk and uncertainty and how they are measured, so that they can be properly managed in a business context. Please add any comments or feedback, and share this presentaiton with your colleagues, thanks! Feel free to contact me via LinkedIn if you have any questions: http://www.linkedin.com/in/kelvinstott Alternatively, please visit or join our LinkedIn group, ’Big Ideas in R&D Productivity & Project / Portfolio Management’: http://www.linkedin.com/groups/Big-Ideas-in-Pharma-R-4322249]]>
Risk and uncertainty are related, but different concepts that many people struggle to understand. This presentation defines and explains the difference between risk and uncertainty and how they are measured, so that they can be properly managed in a business context. Please add any comments or feedback, and share this presentaiton with your colleagues, thanks! Feel free to contact me via LinkedIn if you have any questions: http://www.linkedin.com/in/kelvinstott Alternatively, please visit or join our LinkedIn group, ’Big Ideas in R&D Productivity & Project / Portfolio Management’: http://www.linkedin.com/groups/Big-Ideas-in-Pharma-R-4322249]]> Mon, 12 Mar 2012 20:53:20 GMT /slideshow/kelvin-stott-risk-and-uncertainty/11981004 KelvinStott@slideshare.net(KelvinStott) Understanding Risk & Uncertainty KelvinStott Risk and uncertainty are related, but different concepts that many people struggle to understand. This presentation defines and explains the difference between risk and uncertainty and how they are measured, so that they can be properly managed in a business context. Please add any comments or feedback, and share this presentaiton with your colleagues, thanks! Feel free to contact me via LinkedIn if you have any questions: http://www.linkedin.com/in/kelvinstott Alternatively, please visit or join our LinkedIn group, ’Big Ideas in R&D Productivity & Project / Portfolio Management’: http://www.linkedin.com/groups/Big-Ideas-in-Pharma-R-4322249 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/kelvinstott-riskanduncertainty-120312205323-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Risk and uncertainty are related, but different concepts that many people struggle to understand. This presentation defines and explains the difference between risk and uncertainty and how they are measured, so that they can be properly managed in a business context. Please add any comments or feedback, and share this presentaiton with your colleagues, thanks! Feel free to contact me via LinkedIn if you have any questions: http://www.linkedin.com/in/kelvinstott Alternatively, please visit or join our LinkedIn group, ’Big Ideas in R&amp;D Productivity &amp; Project / Portfolio Management’: http://www.linkedin.com/groups/Big-Ideas-in-Pharma-R-4322249
Understanding Risk & Uncertainty from Kelvin Stott
]]> 50987 16 https://cdn.slidesharecdn.com/ss_thumbnails/kelvinstott-riskanduncertainty-120312205323-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 New Approach to Pharma R&D / PPM /slideshow/kelvin-stott-new-approach-to-pharma-rampd-ppm/10940818 kelvinstottnewapproachtopharmardandppm-13262151040253-phpapp01-120110110953-phpapp01
This presentation explores some of the underlying issues responsible for declining pharma R&D productivity, and provides a new, fully integrated approach to reverse this trend by navigating R&D projects and portfolios through the risk-return landscape in real time. A case study demonstrates how this system can be used in practice to improve the risk-return profile of a Phase 2 development project according to risk appetite. This presentation focuses on R&D in the pharmaceutical industry, however the approach can be used to manage and optimize the risk-return profile of any business asset at any stage of its lifecycle, at any level, in any industry. ]]>
This presentation explores some of the underlying issues responsible for declining pharma R&D productivity, and provides a new, fully integrated approach to reverse this trend by navigating R&D projects and portfolios through the risk-return landscape in real time. A case study demonstrates how this system can be used in practice to improve the risk-return profile of a Phase 2 development project according to risk appetite. This presentation focuses on R&D in the pharmaceutical industry, however the approach can be used to manage and optimize the risk-return profile of any business asset at any stage of its lifecycle, at any level, in any industry. ]]> Tue, 10 Jan 2012 11:08:29 GMT /slideshow/kelvin-stott-new-approach-to-pharma-rampd-ppm/10940818 KelvinStott@slideshare.net(KelvinStott) New Approach to Pharma R&D / PPM KelvinStott This presentation explores some of the underlying issues responsible for declining pharma R&D productivity, and provides a new, fully integrated approach to reverse this trend by navigating R&D projects and portfolios through the risk-return landscape in real time. A case study demonstrates how this system can be used in practice to improve the risk-return profile of a Phase 2 development project according to risk appetite. This presentation focuses on R&D in the pharmaceutical industry, however the approach can be used to manage and optimize the risk-return profile of any business asset at any stage of its lifecycle, at any level, in any industry. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/kelvinstottnewapproachtopharmardandppm-13262151040253-phpapp01-120110110953-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This presentation explores some of the underlying issues responsible for declining pharma R&amp;D productivity, and provides a new, fully integrated approach to reverse this trend by navigating R&amp;D projects and portfolios through the risk-return landscape in real time. A case study demonstrates how this system can be used in practice to improve the risk-return profile of a Phase 2 development project according to risk appetite. This presentation focuses on R&amp;D in the pharmaceutical industry, however the approach can be used to manage and optimize the risk-return profile of any business asset at any stage of its lifecycle, at any level, in any industry.
New Approach to Pharma R&D / PPM from Kelvin Stott
]]> 6416 15 https://cdn.slidesharecdn.com/ss_thumbnails/kelvinstottnewapproachtopharmardandppm-13262151040253-phpapp01-120110110953-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-KelvinStott-48x48.jpg?cb=1599116760 Bold and visionary creative strategic problem solver and systems architect with real entrepreneurial spirit, driven by the need to make a big impact. 15 years of leading change in pharma / biotech R&D strategy and operations, project and portfolio management, innovation, risk and performance management, consulting, start-ups and venture capital. Big picture, long-term forward thinker with deep scientific and business insight. Able to understand the most complex systems and concepts, ask the right questions, join the dots, make sense out of chaos, identify the key issues and underlying drivers, think outside the box, challenge the status quo, and develop and implement long-term solutions... www.linkedin.com/profile/view?id=17597859 https://cdn.slidesharecdn.com/ss_thumbnails/kelvinstott-riskanduncertainty-120312205323-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/kelvin-stott-risk-and-uncertainty/11981004 Understanding Risk &amp; U... https://cdn.slidesharecdn.com/ss_thumbnails/kelvinstottnewapproachtopharmardandppm-13262151040253-phpapp01-120110110953-phpapp01-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/kelvin-stott-new-approach-to-pharma-rampd-ppm/10940818 New Approach to Pharma...